BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16846477)

  • 1. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.
    Peyvandi F; Siboni SM; Lambertenghi Deliliers D; Lavoretano S; De Fazio N; Moroni B; Lambertenghi Deliliers G; Mannuccio Mannucci P
    Br J Haematol; 2006 Jul; 134(2):187-95. PubMed ID: 16846477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies.
    Crawley JT; Scully MA
    Hematology Am Soc Hematol Educ Program; 2013; 2013():292-9. PubMed ID: 24319194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone-induced thrombotic thrombocytopenic purpura in
    Zheng L; Abdelgawwad MS; Zhang D; Xu L; Wei S; Cao W; Zheng XL
    Haematologica; 2020 Apr; 105(4):1107-1119. PubMed ID: 31753928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis.
    de Maat S; Clark CC; Barendrecht AD; Smits S; van Kleef ND; El Otmani H; Waning M; van Moorsel M; Szardenings M; Delaroque N; Vercruysse K; Urbanus RT; Sebastian S; Lenting PJ; Hagemeyer CE; Renné T; Vanhoorelbeke K; Tersteeg C; Maas C
    Blood; 2022 Jan; 139(4):597-607. PubMed ID: 34752601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19.
    Zhang Q; Ye Z; McGowan P; Jurief C; Ly A; Bignotti A; Yada N; Zheng XL
    Res Pract Thromb Haemost; 2023 Jan; 7(1):100010. PubMed ID: 36531671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.
    Xu Z; Luo C; Lai P; Ling W; Wu S; Huang X; Huang L; Zhang G; Du X; Weng J
    Clin Appl Thromb Hemost; 2020; 26():1076029619892684. PubMed ID: 32088973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019.
    Doevelaar AAN; Bachmann M; Hölzer B; Seibert FS; Rohn BJ; Zgoura P; Witzke O; Dittmer U; Brenner T; Paniskaki K; Yilmaz S; Dittmer R; Schneppenheim S; Wilhelm J; Stervbo U; Babel N; Budde U; Westhoff TH
    Sci Rep; 2023 Jun; 13(1):10501. PubMed ID: 37380654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for secondary thrombotic microangiopathy in COVID-19.
    Sweeney JM; Barouqa M; Krause GJ; Gonzalez-Lugo JD; Rahman S; Gil MR
    medRxiv; 2020 Oct; ():. PubMed ID: 33106812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
    Gavriilaki E; Bousiou Z; Batsis I; Vardi A; Mallouri D; Koravou EE; Konstantinidou G; Spyridis N; Karavalakis G; Noli F; Patriarcheas V; Masmanidou M; Touloumenidou T; Papalexandri A; Poziopoulos C; Yannaki E; Sakellari I; Politou M; Papassotiriou I
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAMTS13 protease or lack of von Willebrand factor protects irradiation and melanoma-induced thrombotic microangiopathy in zebrafish.
    Zheng L; Cao L; Zheng XL
    J Thromb Haemost; 2022 Oct; 20(10):2270-2283. PubMed ID: 35894519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis.
    Young JA; Pallas CR; Knovich MA
    Bone Marrow Transplant; 2021 Aug; 56(8):1805-1817. PubMed ID: 33875812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable clinical manifestations of hematopoietic stem cell transplant-associated thrombotic microangiopathy.
    Jia C; Qin M; Wang B; Zhu G; Yan Y
    Pediatr Investig; 2018 Dec; 2(4):253-256. PubMed ID: 32851275
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management.
    Dvorak CC; Higham C; Shimano KA
    Front Pediatr; 2019; 7():133. PubMed ID: 31024873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.
    Gavriilaki E; Anagnostopoulos A; Mastellos DC
    Front Immunol; 2019; 10():337. PubMed ID: 30891033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombotic microangiopathy with lack of ADAMT13 activity after allogeneic hematopoietic stem cell transplantation: a case report and literature review].
    Li WY; Li XL; He XF; Ma X; Han Y; Wu DP; Sun AN
    Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1072-1074. PubMed ID: 29365405
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.
    Qi J; Wang J; Chen J; Su J; Tang Y; Wu X; Ma X; Chen F; Ruan C; Zheng XL; Wu D; Han Y
    Ann Hematol; 2017 Nov; 96(11):1849-1855. PubMed ID: 28801815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.
    Zeisbrich M; Becker N; Benner A; Radujkovic A; Schmitt K; Beimler J; Ho AD; Zeier M; Dreger P; Luft T
    Bone Marrow Transplant; 2017 Oct; 52(10):1399-1405. PubMed ID: 28650448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant-associated thrombotic microangiopathy: opening Pandora's box.
    Gavriilaki E; Sakellari I; Anagnostopoulos A; Brodsky RA
    Bone Marrow Transplant; 2017 Oct; 52(10):1355-1360. PubMed ID: 28287636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
    Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
    Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient.
    Munchel A; Chen A; Symons H
    Clin Pediatr Emerg Med; 2011 Sep; 12(3):233-244. PubMed ID: 25411564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.